Publications by authors named "Karndumri Krittadhee"

Background: The coronavirus disease (COVID-19) outbreak in Bangkok led to a shortage of hospital capacity, and a home isolation system was set up. We described the process of diabetes self-management education and support (DSMES) and glycemic management via telemedicine, along with outcomes in home-isolated patients with COVID-19 infection.

Methods: A retrospective chart review of glucose values, insulin and corticosteroids use, and outcomes was performed.

View Article and Find Full Text PDF
Article Synopsis
  • The study analyzes trends and factors related to recurrence and outcomes of papillary thyroid cancer (PTC) in Thai patients over a 30-year period.
  • Patients with PTC showed a rise in cases of papillary thyroid microcarcinoma (PTMC), with high recurrence rates observed in some cases, especially among patients aged 55 and older.
  • Overall, while the prognosis for PTC is generally good, one-quarter of PTMC patients exhibited more aggressive disease characteristics, but coexistence with Hashimoto's thyroiditis was linked to lower recurrence rates.
View Article and Find Full Text PDF

Background: In 2018, the American Joint Committee on Cancer (AJCC) 8 edition (AJCC8) was introduced to replace the previous version (AJCC7) due to superiority of AJCC8 over AJCC7 for better prediction of survival from thyroid cancer.

Aim: To compare AJCC staging systems with the American Thyroid Association (ATA) risk classification for the prediction of 5-year disease-free survival (DFS), and 5-year disease-specific survival (DSS) in Thai patients.

Methods: We retrospectively reviewed all patients with histopathologic diagnosis of DTC who were treated at Theptarin Hospital, Bangkok, Thailand from 1987 to 2019.

View Article and Find Full Text PDF

Background: The treatment of hyperthyroid Graves' disease (GD) varies considerably among geographic areas. In this study, we aimed to evaluate practice patterns and treatment outcomes in Thai patients with hyperthyroid GD.

Methods: A retrospective cohort study over 35 years (1985-2019) in patients with hyperthyroid GD was conducted.

View Article and Find Full Text PDF

Background: Methimazole (MMI) has been advocated as a preferred option for most Graves disease (GD) patients. However, long-term remission after a course of MMI treatment is achieved in only 20% to 40% of patients, depending on the duration of follow-up.

Objective: To evaluate clinical factors for predicting relapse of GD in Thai patients after MMI treatment.

View Article and Find Full Text PDF
Article Synopsis
  • Insulin-induced lipodystrophy is a common issue in insulin-treated diabetes patients in Thailand, particularly among those with longer durations of insulin use; it affects about 37.3% of patients studied.
  • The study involved 400 patients and found that long-standing Type 1 diabetes (T1DM) patients had the highest prevalence of lipohypertrophy (LH) at 57.5%, with incorrect injection site rotation significantly increasing the risk.
  • Lipodystrophy increases the risk of unexplained hypoglycemia seven-fold, highlighting the need for better awareness and education regarding proper injection techniques among patients.
View Article and Find Full Text PDF

Background: Thyrotoxic periodic paralysis (TPP) is a unique manifestation of Graves' disease. While it is uncommon in Asian, it is extremely rare in Caucasian patients (0.1-0.

View Article and Find Full Text PDF

Summary: In this case report, we describe a 37-year-old male who presented with fever and tender neck mass. Neck ultrasonography revealed a mixed echogenic multiloculated solid-cystic lesion containing turbid fluid and occupying the right thyroid region. Thyroid function tests showed subclinical hyperthyroidism.

View Article and Find Full Text PDF
Article Synopsis
  • Previous research indicated that hemoglobin (Hb) and hematocrit (Hct) levels stabilize 24 hours after a red blood cell (RBC) transfusion, suggesting a need for quicker monitoring.
  • This prospective study enrolled 60 patients to assess Hb and Hct levels at 1, 4, and 24 hours post-transfusion, with no significant differences found in the levels at these times.
  • The findings suggest that target Hb and Hct levels can be effectively determined as soon as one hour after the transfusion, potentially allowing for more timely treatment.
View Article and Find Full Text PDF